about
The anticonvulsant zonisamide reduces ethanol self-administration by risky drinkersThe efficacy of mirtazapine in the treatment of cocaine dependence with comorbid depression.Quetiapine for treatment of alcohol dependence.Open label trial of the tolerability and efficacy of zonisamide in the treatment of alcohol dependenceDeep brain stimulation of the nucleus accumbens shell attenuates cocaine priming-induced reinstatement of drug seeking in ratsHaloperidol overdosing in the treatment of agitated hospitalized older people with delirium: a retrospective chart review from a community teaching hospital.Medial forebrain stimulation enhances intracranial nociception and attenuates morphine analgesia suggesting the existence of an endogenous opioid antagonist.Zonisamide decreases ethanol intake in rats and mice.Frontal lobe GABA levels in cocaine dependence: a two-dimensional, J-resolved magnetic resonance spectroscopy study.Deep brain stimulation of the nucleus accumbens reduces ethanol consumption in rats.A benzodiazepine mood effect scale: reliability and validity determined for alcohol-dependent subjects and adults with a parental history of alcoholism.Adenosine agonists CGS 21680 and NECA inhibit the initiation of cocaine self-administration.Additive effects of intra-accumbens infusion of the cAMP-specific phosphodiesterase inhibitor, rolipram and cocaine on brain stimulation reward.Effects of cue exposure on brain glucose utilization 8 days after repeated cocaine administration.Low-dose risperidone as adjunctive therapy for irritable aggression in posttraumatic stress disorder.The effects of cocaine on the rate independent brain stimulation reward threshold in the mouse.Effects of morphine on brain-stimulation reward thresholds in young and aged rats.Increased sensitization to morphine-induced oral stereotypy in aged rats.Efficacy screening trials of paroxetine, pentoxifylline, riluzole, pramipexole and venlafaxine in cocaine dependence.Nefazodone treatment of cocaine dependence with comorbid depressive symptoms.Prefrontal GABA levels in cocaine-dependent subjects increase with pramipexole and venlafaxine treatment.Pharmacokinetics and pharmacodynamics of multiple sublingual buprenorphine tablets in dose-escalation trials.Underrecognition of weight loss in community-dwelling elderly adults.Nociceptive threshold and analgesic response to morphine in aged and young adult rats as determined by thermal radiation and intracerebral electrical stimulation.Low-dose apomorphine attenuates morphine-induced enhancement of brain stimulation reward.Alterations in pharmacodynamics of anxiolytics in abstinent alcoholic men: subjective responses, abuse liability, and electroencephalographic effects of alprazolam, diazepam, and buspirone.The type IV phosphodiesterase inhibitors, Ro 20-1724 and rolipram, block the initiation of cocaine self-administration.Bromocriptine, a D2 receptor agonist, lowers the threshold for rewarding brain stimulation.The effects of amfonelic acid alone and in combination with naloxone on brain-stimulation reward.Decreased EEG Sensitivity to Alprazolam in Subjects with a Parental History of Alcoholism
P50
Q33637610-D0A914C7-9AED-4A8F-9C36-63550B651990Q34119362-2B5D4FF3-E82F-4D14-959E-B685A1895D98Q35878627-E2A72534-0F78-4232-9148-1B13EFB7C47AQ36341608-77568266-205F-4EAB-AB89-7CB3C76F1623Q36978517-24251472-60CE-44A6-8202-B069FA3C9945Q38105039-25FC0CB1-55DC-47B5-A1C0-2769024BC8F0Q40199869-C6A01930-5E36-4963-BF91-09A5889A5B32Q40469992-B188BCC2-9560-411B-A36A-204E599A377AQ40511573-5249B90D-3994-4152-AADA-7722250B4B9DQ41999212-F60AEBC1-6F7A-47BB-9162-D04BCED9791AQ43647642-A5BFB549-36A0-49C9-B268-055C3E9C7746Q43722677-1A9D5B1D-0372-4A87-A1C8-9878B6E16B2AQ43758513-8892BB93-B30E-480A-95EF-FE1C76F723E1Q44136456-A0ADA35E-0088-447B-9375-BE0135302A95Q44364171-60D7F593-8E1A-44F2-AE78-43344271BB82Q45075317-5659CD1E-09A7-49A4-8278-F8DB62904A89Q45175573-AAC85979-9E02-46D9-87EA-EB24B2129482Q45175578-878C7688-2C67-4E87-A0A8-BDACE3EBBBADQ45282164-D072F066-C24C-4AAA-8913-C8274E7823F0Q45282166-3D366B94-19F2-4826-B346-B0932F4ACE68Q46630816-61BCA029-C324-471C-AB3A-6F64330EF442Q46908029-BBEA57C6-8670-454E-8B22-7C2E11B86961Q47272701-99921EF3-2BF7-4787-A797-E4C2FEB7EAB7Q48506953-4564FB26-C280-47B2-9E02-A08F77F02E01Q48932175-A5FD5990-BC01-470A-A640-4D9A3EEE5147Q51107985-97A1680E-9038-4D27-BC32-CF0C6E398FC5Q51475470-BCBDD63E-AB66-4916-9159-93D7C556A939Q52212600-9DE764C9-A6BD-4D00-BD49-76299FF1F7BFQ52246917-59051A51-4EFE-4C56-98AE-0A396A82128CQ59741614-3E9141C3-ED29-495D-90F3-C53B538F5DE2
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Clifford M Knapp
@ast
Clifford M Knapp
@en
Clifford M Knapp
@es
Clifford M Knapp
@nl
Clifford M Knapp
@sl
type
label
Clifford M Knapp
@ast
Clifford M Knapp
@en
Clifford M Knapp
@es
Clifford M Knapp
@nl
Clifford M Knapp
@sl
prefLabel
Clifford M Knapp
@ast
Clifford M Knapp
@en
Clifford M Knapp
@es
Clifford M Knapp
@nl
Clifford M Knapp
@sl
P106
P21
P31
P496
0000-0003-4482-7678